COHANCE LIFESCIENCES
Back to Cashflow Statement
|
COHANCE LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹368 Cr | ₹673 Cr | ₹385 Cr | ₹457 Cr | ₹330 Cr |
What is the latest Cash Flow from Operating Activities ratio of COHANCE LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹368 Cr |
| Mar2025 | ₹673 Cr |
| Mar2024 | ₹385 Cr |
| Mar2023 | ₹457 Cr |
| Mar2022 | ₹330 Cr |
How is Cash Flow from Operating Activities of COHANCE LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹368 Cr | -45.30 | |
| Mar2025 | ₹673 Cr | 75.00 | |
| Mar2024 | ₹385 Cr | -15.84 | |
| Mar2023 | ₹457 Cr | 38.54 | |
| Mar2022 | ₹330 Cr | - | |
Compare Cash Flow from Operating Activities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,962.6 Cr | 0.3% | -0.3% | -41.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | 0.3% |
-0.3% |
-41.7% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses